RUKOBIA 600 mg, extended-release tablet 60 tablets
Active ingredients: Fostemsavir, TROMÉTHAMINE DE FOSTEMSAVIR
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RUKOBIA 600 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)
- Marketing authorisation holder
- VIIV HEALTHCARE (PAYS-BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 May 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69610664CIP73022029CIP133400930220290Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TROMÉTHAMINE DE FOSTEMSAVIRcomprimé | — | SA |
| FOSTEMSAVIRcomprimé | 600 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.